At a glance
ClinicalIndex Comparison RecordN/ACompleted· 500 enrolled
Drug / intervention
MitraClip NT Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MitraClip NT System Post -Marketing Surveillance Study
In Brief
An observational study evaluating MitraClip NT System for Mitral Regurgitation and Mitral Valve Regurgitation. Completed, enrolled 500 participants across 40 sites.
Detailed Summary
The purpose of the MitraClip post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of the clinical use.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMitral Regurgitation, Mitral Valve Regurgitation
CountriesJapan
CollaboratorsAbbott
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartApr 2018
First PostedApr 2018
Primary CompletionMar 2019
Study CompletionMar 2022
TodayJul 2026
First PostedApr 18, 2018
Enrollment StartApr 2, 2018
Primary CompletionMar 31, 2019
Study CompletionMar 23, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 8.2 years ago
Interventions
MitraClip NT Systemdevice
Percutaneous mitral valve repair using MitraClip NT System